1. Home
  2. AMRX vs HSAI Comparison

AMRX vs HSAI Comparison

Compare AMRX & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$13.05

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo Hesai Group each ADS represents one Class B ordinary share

HSAI

Hesai Group each ADS represents one Class B ordinary share

HOLD

Current Price

$24.21

Market Cap

3.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
HSAI
Founded
2002
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.8B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
AMRX
HSAI
Price
$13.05
$24.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$14.75
$31.58
AVG Volume (30 Days)
1.3M
1.9M
Earning Date
05-01-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
157.89
N/A
EPS
0.22
N/A
Revenue
N/A
N/A
Revenue This Year
$4.48
$46.32
Revenue Next Year
$7.13
$41.24
P/E Ratio
$59.61
$61.18
Revenue Growth
N/A
N/A
52 Week Low
$7.01
$10.62
52 Week High
$15.42
$30.85

Technical Indicators

Market Signals
Indicator
AMRX
HSAI
Relative Strength Index (RSI) 55.90 58.17
Support Level $12.50 $22.35
Resistance Level $13.54 $28.64
Average True Range (ATR) 0.33 0.95
MACD 0.15 0.57
Stochastic Oscillator 87.42 96.21

Price Performance

Historical Comparison
AMRX
HSAI

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three-dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with enhanced advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. Geographically, the company operates in North America, Mainland China, Europe, and Other regions.

Share on Social Networks: